Although hepatocyte transplantation (HCTx) is expected to become a useful therapy for human liver diseases, allogenic hepatocytes still tend to be rejected within a short period due to host immunosurveillance. In the present study, we investigated the effect of prior bone marrow transplantation (BMTx) for the engraftment of allogenic hepatocytes using the analbuminemic rat transplantation model. The hepatocytes of Lewis (LEW) rats were not accepted in the liver of retrorsine (RS)/partial hepatectomy (PH)-treated analbuminemic F344 (F344-alb) rats, which express the disparate major histocompatibility complex (MHC) against that of LEW rats. Prior BMTx with the LEW bone marrow cells (BMCs) after sublethal irradiation achieved acceptance and repopulation of LEW hepatocytes in the liver of the RS/PH-treated F344-alb rats, associated with elevation of serum albumin. The replacement of hepatic parenchyma with albumin positive (Alb + ) donor hepatocytes and elevation of serum albumin levels were dependent on the bone marrow reconstitution by donor BMCs, which was more efficiently achieved by intrabone marrow (IBM)-BMTx than by intravenous (IV)-BMTx. Our results demonstrate that efficient bone marrow reconstitution by IBM-BMTx enables the replacement of the hepatic parenchyma with allogenic hepatocytes in RS/PH-treated analbuminemic rats without immunosuppressants.
INTRODUCTION
ease model) (42). Furthermore, transplanted cells can preferentially proliferate over host hepatocytes by regenerating stimuli generated by partial hepatectomy (PH), Hepatocyte transplantation (HCTx) is an alternative to orthotropic liver transplantation for the treatment of when host hepatocytes cannot proliferate due to chemical-or irradiation-induced DNA damage (22, 40) . human liver diseases (25, 32, 36) . The liver is thought to be the most desirable site for HCTx, because trans-One of the main factors that limit the clinical application of HCTx, however, is the large cellular loss follow-planted cells could physiologically function by obtaining nutrients, growth factors, and hormones present in the ing HCTx (18). In the early phase following HCTx, the majority of transplanted hepatocytes infused into the portal blood and interacting with other liver cells and the extracellular matrix (17, 27, 33) . HCTx could be espe-portal circulation are trapped in the hepatic portal venule and the sinusoids around the portal tract, and thereafter cially effective if the transplanted cells repopulate and replace the host hepatic tissues. This has been observed are cleared by the cells of the innate immune system including granulocytes, macrophages, and Kupffer cells following HCTx when host hepatocytes possess hereditary defects, such as in urokinase plasminogen activator (18, 29) . Only a small number of cells thus become integrated into the host hepatic plates by disrupting the si-transgenic mice (31) , fumaryl acetoacetate hydrolasedeficient mice (tyrosinemia type I model) (30) , multiple nusoidal endothelium and then survive without being attacked by innate immune cells. In the case of allogenic drug resistance gene 2 (MDR2) gene knockout deficient mice (9) , and Long-Evans Cinnamon rats (Wilson's dis-HCTx, however, transplanted cells stimulate the adap-1480 INAGAKI ET AL.
tive immune system and then are rejected mainly by the In this study, we investigated allogenic intrahepatic HCTx using F344-alb rats as recipients and Lewis (LEW) immune responses mediated by CD4 + and CD8 + T lymphocytes (8, 18, 37) . rats as donors, which express disparate MHC. We used the retrorsine (RS)/partial hepatectomy (PH) treatment HCTx would therefore be much more attractive if the cellular loss following HCTx could be avoided. Up to for the expansion of the transplanted allogenic hepatocytes, because transplanted normal hepatocytes can ex-now, a number of experiments have been performed to attempt to prevent immunological rejection. These have pand by responding to the growth stimuli generated by PH, while the host hepatocytes are unable to proliferate included the administration of immunosuppressants such as cyclosporine and rapamycin (5) , depletion of CD4 + or due to RS toxicity. We herein demonstrate that efficient bone marrow reconstitution by allogenic BMTx pro-CD8 + T lymphocytes using anti-T-lymphocyte monoclonal antibodies (7) , interference with costimulation vides tolerance to allogenic HCTx and that IBM-BMTx is superior to IV-BMTx for this purpose. pathways between antigen-presenting cells and cytotoxic T lymphocytes by the administration of a CTLA4 Ig MATERIALS AND METHODS and/or anti-CD40 antibody (38) , and transduction of im-Experimental Animals munomodulatory genes such as the adenovirus E3 into the donor cells in vitro prior to HCTx (24). However, F344 and LEW rats were purchased from Charles considering the future application of allogenic HCTx for River Japan (Yokohama, Japan), and specific pathogenhuman liver diseases, prolonged immunosuppressive free F344-alb rats were maintained in the Asahikawa treatment may therefore be a large long-term obstacle to Medical University Animal Laboratory. All rats were the successful performance of HCTx.
maintained on daily cycles of an alternating 12-h light/ Hematopoietic reconstitution by bone marrow transdark cycle with food and water available ad libitum. The plantation (BMTx) has been shown to provide host tolprocedures performed on the animals were approved by erance in various models of transplantation (14). It has the animal care and use committee of the Asahikawa been demonstrated that when host bone marrow is re-Medical University according to the guidelines for huconstituted by donor BMTx after lethal irradiation, allomane care of laboratory animals. genic HCTx is feasible between the mouse strains ex-Animal Treatment and Cell Transplantation pressing the disparate major histocmpatibility complex (MHC) (26, 41) . In this setting, hepatocytes of the third-Male F344-alb rats (6 to 8 months old) were assigned to different groups as shown in Figure 1 . Group 1 re-party mouse strains were rejected, thus indicating that donor-specific immunotolerance was important for the ceived syngeneic F344 HCTx, while group 2 underwent allogenic LEW HCTx. Group 2 was then further divided successful engraftment of allogenic hepatocytes (26). Furthermore, human HCTx to immunodeficient rodent into three groups: group 2a without the bone marrow reconstitution, group 2b with bone marrow reconstitu-recipients has been achieved by prior human BMTx (4, 20) . On the other hand, it has been reported that intra-tion by IV-BMTx, and group 2c with bone marrow reconstitution by IBM-BMTx. Groups 2b and 2c were ad-bone marrow-bone marrow transplantation (IBM-BMTx) has been reported to result in more efficient bone mar-ministered a single dose of irradiation by placing the rats in a container equipped with two opposing 137 Cs γ-ray row reconstitution by donor cells compared to the intravenous infusion of BMCs (IV-BMTx), even after low sources (Gamma Cell 40, Atomic Energy of Canada, Ottawa, Canada). BMCs were isolated from the femurs and doses of irradiation in rodents (11, 16, 21, 28) .
We have previously reported that the transplantation tibia of 6-to 7-week-old male donor LEW rats, centrifuged with Histopaque 1077 (Sigma-Aldrich, St. Louis, model using analbuminemic F344 (F344-alb) rats as recipients and F344 rats as donors is an excellent way to MO) at 1,800 rpm for 30 min, and washed in modified Eagle medium solution (Sigma-Aldrich). A suspension monitor the efficiency of intrahepatic HCTx (27, 43) . F344-alb rats have the genetic background of F344 rats of 5 × 10 7 BMCs suspended in physiological phosphatebuffered saline was injected into the penile vein for IV-and are otherwise normal except for a seven base pair deletion downstream of the exon H splice site within the BMTx (group 2b). The same number of cells were suspended in a collagen gel matrix (Nitta Gelatin, Osaka, ninth intron of the albumin gene, which leads to an inability of hepatocytes to produce albumin (12) . In this Japan) and infused into the bone marrow cavity of the femur as described previously for IBM-BMTx (group model, the efficiency of HCTx can be monitored by elevation of serum albumin levels and immunohistochemi-2c) (34) . The recipient F344-alb rats were administered one dose of RS (Sigma-Aldrich, 30 µg/g body weight), cal albumin staining of hepatic tissues, and hematopoietic reconstitution by donor BMCs can be examined by intraperitoneally after 2 weeks, and were subjected to PH and immediately transplanted with 2 × 10 6 hepato-PCR for albumin genes using DNA isolated from the recipient bone marrow. cytes (cellular viability over 98%) via the portal vein (13.2 ± 1.6 cm 2 /rat) were obtained on a computer using an image scanner, and the albumin positive (Alb + ) hepatocyte areas in the hepatic tissues were measured using the ImageJ software package (rsb.info.nih.gov/ij/), and the rate (%) was determined for each recipient rat.
PCR for the Albumin Genes
The extent of hematopoietic substitution in the recipient rat bone marrow was investigated by PCR using the albumin gene sequence as a marker. PCR primers were designed to amplify a region including the seven base pairs lacking in the analbuminemic albumin gene (2, 19, 43) , and the forward primer was tagged with 6-fluoreceine amidide (6-FAM). DNA was isolated from bone marrow of the recipient F344-alb rats using DNAzol (Molecular Research Center, Cincinnati, OH), and 40 cycles of PCR were performed using the DNA at 95°C fourth week after HCTx by the bromocresol green method (23) using an automatic analyzer (Hitachi 7180, Tokyo, Japan) and by an enzyme-linked immunosorbent after 4 weeks. Hepatocytes were isolated from 8-weekassay (ELISA) (Bethyl Lab, Montgomery, TX). old male donor F344 and LEW rats using the two-step collagenase perfusion technique (3) and were suspended Statistical Analysis in Hanks' balanced salt solution (Sigma-Aldrich). At the The relationship between Alb + hepatocyte areas in the eighth week all the recipient rats that survived were sacliver tissues and the elevation of serum albumin levels rificed under ether anesthesia.
in the recipient rats at the fourth week after HCTx was statistically analyzed by a simple linear regression test Histology and Immunohistochemistry using the JMP7.0.1 software (SAS Institute, Cary, NC). The livers were perfusion fixed with periodate-lysineparaformaldehyde (PLP) solution via the portal vein and RESULTS processed for histological and immunohistochemical Irradiation Doses and Survival Rates analysis (27) . Three slices were cut out from each hepatic lobe, fixed in a PLP solution at 4°C overnight,
We first investigated the optimal irradiation dose for bone marrow reconstitution by BMTx using F344-alb dehydrated through a graded ethanol series, and embedded in paraffin. The tissue specimens were cut into 3-µm-rats. After 7.5 or 8.0 Gy whole body irradiation, 6/6 and 3/6 F344-alb rats survived until 2 weeks without BMTx, thick sections and stained with hematoxylin and eosin (H&E). For the immunohistochemistry examinations, respectively (data not shown). When F344-alb rats received BMTx (5 × 10 7 cells), either by IV-BMTx (group the slides were deparaffinized, incubated with 3% H 2 O 2 , reacted with 1:500 diluted rabbit anti-rat albumin anti-2b) or IBM-BMTx (group 2c) ( Fig. 2 ) after 8.0 Gy irradiation, all the rats (12/12 in each group) survived until body (Cappel, Malver, PA), and incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG poly-the fourth week and appeared healthy. When irradiated with 8.5 Gy, however, all F344-alb rats (6/6) died within mer (Dako, Carpinteria, CA). The antibody binding was visualized using diaminobenzidine substrate-chromogen 2 weeks even after F344 IBM-BMTx (data not shown). Bone marrow reconstitution by BMTx was therefore system (Dako), followed by counterstaining with hematoxylin. Digital images of the albumin-stained sections performed after 8.0 Gy irradiation. Although all recipient F344-alb rats survived until the Histological Changes of the Recipient Livers fourth week, several of rats (5/11 in group 1, 4/10 in The livers of the recipient rats that received either group 2a, 6/12 in group 2b, and 6/12 in group 2c) died syngeneic (group 1) or allogenic HCTx (group 2) showed within 2 weeks after PH/HCTx during the fourth week megalocytosis (enlarged hepatocytes with huge nuclei) (Fig. 2) . This is likely due to persistent hepatic damage and frequent clusters of small-sized hepatocytes, as preby irradiation/RS (group 2b and 2c) or RS (group 1 and viously reported (22). Although the livers of F344-alb 2a) and PH impaired liver functions, and it is possible with syngeneic F344 HCTx (group 1) showed either no that the transplanted hepatocytes could not compensate or only weak inflammation ( Fig. 4a-1) , those of F344for liver functions, as it takes time for the transplanted alb with allogenic LEW HCTx showed a strong degree hepatocytes to repopulate the liver following transplanof inflammatory cell infiltration, consisting mainly of tation (6) .
granulocytes, in the portal tract and occasionally in sinusoids regardless to the prior BMTx ( Fig. 4b-1 ). No in-Bone Marrow Reconstitution After BMTx flammatory cell infiltration, however, was seen within We next investigated bone marrow reconstitution usthe Alb + hepatocyte areas in group 1 or in group 2b and ing the albumin gene sequence as a marker in the recipi-2c ( Fig. 4a-2 , b-2). ent F344-alb rats that survived until the eighth week. When PCR was performed to target the sequences span-Replacement of Hepatic Parenchyma ning the seven base pair (bp) deletion in the analbumi-With Alb + Hepatocytes nemic albumin gene, the normal DNA fragment (68 bp) was generated from the F344 genomic DNA, while the The hepatic tissue areas of recipient F344-alb rats that received syngeneic F344 HCTx (group 1) were re-analbuminemic DNA fragment (61 bp) was observed for the F344-alb genomic DNA as described previously placed by Alb + hepatocytes, ranging 4.5-28.7% (Table  1 , Fig. 5a ). In group 2a that received LEW HCTx with-(2,19,43) ( Fig. 3a, b ). When DNA from F344 and F344alb was mixed in various ratios, the one pattern became out BMTx, their liver tissues did not contain any Alb + hepatocyte areas (Fig. 5b) . In 1/6 recipient F344-alb rats dominant, when the amount of one DNA was present in a 9:1 excess ratio to the other (Fig. 3b ). One of six of that received LEW IV-BMTx followed by LEW HCTx (group 2b), 44.5% of the liver tissue areas were replaced the recipients with LEW IV-BMTx (group 2b) showed a normal pattern, while 5/6 rats showed an aberrant pat-by Alb + hepatoyctes, while the liver tissues of other five rats did not contain any Alb + hepatocyte areas ( Fig. 3c ). In the group with LEW IBM-BMTx (group 2c), 6/6 rats showed a normal pattern (Ta- Fig. 5c, d) . The six recipient F344-alb rats with LEW IBM-BMTx followed by LEW HCTx (group 2c) had ble 1, Fig. 3c ). Therefore, bone marrow reconstitution was much more efficiently achieved by IBM-BMTx liver tissues that were replaced with Alb + hepatocytes, ranging from 4.8% to 58.4% ( Table 1 , Fig. 5e, f) . The than IV-BMTx. Table 1 ) showed the normal pattern, while the others (represented by #2 in Table 1 ) showed aberrant patterns. All rats in group 2c (represented by #6 in Table 1 ) showed only the normal pattern. replacement of the liver tissues by the allogenic LEW eighth week (Table 1) . ELISA showed the albumin levels to also increase in the same recipient rats (6/6 rats in Alb + hepatocytes was clearly dependent on the bone marrow reconstitution by the donor LEW BMCs (Table 1) . group 1, 1/6 rat in group 2b, and 6/6 rats in group 2c) ( Table 1) . These values roughly corresponded to 5-80% Elevation of Serum Albumin Levels of the serum albumin levels of untreated F344. The increase in the serum albumin levels in the recipient F344-Although the serum albumin levels of analbuminemic alb rats was correlated with the degree of replacement rats have been reported to be less than 0.0005 g/dl (10), of hepatic parenchyma with Alb + hepatocytes (p = 0.007) those of untreated F344-alb detected by the bromocresol (Fig. 6 ). green method was around 1.0 g/dl, most likely because this method is not very specific to albumin (23). We DISCUSSION therefore examined the serum albumin levels also by ELISA, which can specifically detect rat albumin. The
In the present study, we succeeded in performing the transplantation of allogenic LEW hepatocytes into the bromocresol green method demonstrated the albumin levels to increase above the levels in untreated F344-alb F344-alb liver and in replacing the RS/PH-treated liver tissues with allogenic HCTx by prior BMTx after suble-in 6/6 recipient rats with syngeneic F344 HCTx (group 1), 1/6 rats with LEW IV-BMTx/HCTx (group 2b), and thal irradiation. This was confirmed by immunohistochemistry, which showed an increase in Alb + hepatocyte 6/6 rats with LEW IBM-BMTx/HCTx (group 2c) at the areas in the liver tissues (Table 1, Fig. 5 ) and an eleva-HCTx to be feasible when combined with the prior donor BMTx (4, 20, 26, 28, 35) . tion of serum albumin levels in recipient rats (Table 1) , and there was a correlation between the results (Fig. 6) .
A histological analysis revealed that, although there were no or minimal inflammatory signs in the liver tis-Furthermore, the replacement of host liver tissue with the allogenic LEW Alb + hepatocytes was dependent on sues of the recipient F344-alb with syngeneic HCTx (group 1) ( Fig. 4a-1) , those of the recipient F344-alb the bone marrow reconstitution by the donor LEW BMCs (Table 1) . No replacement of liver tissues by the with allogenic HCTx (groups 2a, 2b, and 2c ) exhibited strong inflammatory cell infiltration in the portal areas donor hepatocytes occurred without the prior donor BMTx (group 2a), consistent with previous reports in and occasionally in sinusoids regardless of BMTx status ( Fig. 4b-1 ). Most hepatocytes infused into the portal cir-which allogenic hepatocytes survived only few days after HCTx without immunosuppression or BMTx (7, culation have been known to be trapped within the portal veins and sinusoids around the portal areas and thus are 18). Our results are in line with those obtained in previous studies reporting either allogenic or xenogenic killed by innate immune cells such as granulocytes, macrophages, and Kupffer cells in early phases follow-shown). However, no inflammatory cell infiltration was observed in the Alb + hepatocyte areas of the liver that ing allogenic and syngeneic HCTx (18). Strong inflammatory infiltration after allogenic HCTx suggested that received allogenic HCTx with BMTx (groups 2b and 2c), thus indicating that there might have been no immu-stronger early rejection might have more occurred more frequently than with syngeneic HCTx (groups 2a, 2b, nological attack against the repopulated allogenic hepatocytes ( Fig. 4b-2 ). and 2c). It is also possible that the graft versus host reaction might have occurred in the liver in groups 2b and
The replacement rate of host liver tissues by syngenic HCTx in RS/PH-treated F344 rats is approximately 40-2c, which received the allogenic BMTx, although no such reaction was detected in other tissues (data not 60% at 4 weeks after HCTx and as much as 95% at and 2c) in the present study, might have contributed to the expansion of transplanted allogenic hepatocytes. The results of Streez et al. (35) and our present study suggest that allogenic hepatocytes can therefore expand within the host liver if appropriate growth stimuli and growth advantages are present. According to the site of allogenic HCTx, some studies have used the spleen or subrenal capsules (26, 28, 41) , while other studies used the liver (13, 24, 35, 39) . Because the expansion of transplanted cells in sufficient numbers is necessary to compensate for the impaired host liver functions, the liver might be an ideal site not only as a physiological site for hepatocytes to function, but also contain sufficient space for the transplanted hepatocytes to expand.
PCR examination of the albumin gene for host bone marrow DNA revealed 1/6 rats in group 2b and 6/6 rats Figure 6 . Correlation between the serum albumin levels and in group 2c showed a normal albumin gene pattern, sugthe replacement rates of liver tissues by Alb + hepatocytes in the recipient F344-alb (p = 0.007). Open circles: group 1; gray gesting that more than 90% BMCs were of donor origin, circle: group 2b; black circles: group 2c.
because the normal albumin gene pattern was observed when donor DNA was present at a 9:1 ratio excess against the recipient DNA (Fig. 3b ). The replacement of hepatic tissues by Alb + hepatocytes was only observed 1 year after HCTx, respectively (22, 39) . However, the replacement rate varied greatly between the syngeneic in the recipient rats of which bone marrow was reconstituted by the donor BMCs (Table 1, Fig. 5c ). Bone mar-HCTx group (group 1; 4.6-28.7%) as well as the allogenic HCTx group (group 1; 4.8-58.4%) ( Table 1 ). Such row reconstitution was much more efficient by IBM-BMTx than IV-BMTx (6/6 vs. 1/6 rats) as consistent variation might be due to the inconsistent efficiency regarding the infusion of hepatocytes into the portal vein with previous reports (11, 16, 21, 28) . F344-alb and LEW rats used in this study express rather than as a result of the immunological mechanism, because almost the same degree of variation was seen in disparate MHC, RT1 lv1 , and RT1 l , respectively. However, this combination demonstrates partial rather than both the syngeneic F344 HCTx without BMTx (group 1) and allogenic LEW HCTx with IBM-BMTx (group complete allogenicity (15), and reciprocal heart transplantation between F344 and LEW rats induced a 2c). On the other hand, the liver of the recipient rats (group 1 and groups 2b, 2c) contained about 15-150 weaker rejection than the complete MHC mismatched combination, such as F344 (RT1 l ) and Black Norway albumin + areas/cm 2 liver section 4 weeks after HCTx (data not shown), thus implying that about 600-18,000 rats (RT1 n ) (1) . When considering the clinical applications of allogenic HCTx, it is necessary to confirm clusters of Alb + hepatocytes were present within the liver. If each Alb + hepatocyte cluster was formed by the whether or not allogenic HCTx would be feasible between rats with complete MHC mismatched combina-expansion of a single transplanted hepatocyte, then the engraftment of about 600-18,000 donor hepatocytes per tions.
There are many hurdles that must still be overcome liver might be sufficient for the extensive replacement of the liver tissue by HCTx.
to achieve the successful clinical application of allogenic HCTx, such as the efficient isolation of viable hepato-Only a few previous studies of allogenic HCTx with BMTx have performed special treatments for expansion cytes from small donor hepatic tissues, the protection of transplanted hepatocytes from the innate and acquired of transplanted cells. Streez et al. (35) , however, reported that when allogenic hepatocytes of human α1immune system, the efficient engraftment of transplanted hepatocytes into chronically injured hepatic tissues, and antitrypsin transgenic FVB mice were transplanted in the liver of BALB/C mice with prior BMTx, CD4 + lym-efficient methods for the massive repopulation of transplanted hepatocytes. However, HCTx might be espe-phocytes infiltrating in the host liver augmented apoptosis of host hepatocytes, which may have facilitated liver cially efficient under conditions in which there are large selective advantages for transplanted hepatocytes, such regeneration and the expansion of donor cells. It is possible that, in addition to the RS/PH treatment, the liver as with acute and chronic hepatic failure or inherited liver disorders (i.e., ornithine transcarbamylase defi-damage caused by the inflammatory cell infiltration as observed in the allogenic LEW HCTx group (groups 2b ciency, tyrosinemia type I, α1-antitrypsin deficiency, 
